The older Parkinson's disease drugs pergolide and cabergoline have been linked to heart problems. Are there any new Parkinson's drugs which are safer for patients with heart risks?

Bibliographische Detailangaben
Veröffentlicht in:	Heart advisor. - 1999. - 12(2009), 8 vom: 18. Aug., Seite 8
Format:	Aufsatz
Sprache:	English
Veröffentlicht:	2009
Zugriff auf das übergeordnete Werk:	Heart advisor
Schlagworte:	Journal Article Antiparkinson Agents Dopamine Agonists Ergolines Pergolide 24MJ822NZ9 Cabergoline LL60K9J05T


LEADER	01000naa a22002652 4500
001	NLM204636604
003	DE-627
005	20231223232417.0
007	tu
008	231223s2009 xx \|\|\|\|\| 00\| \|\|eng c
028	5	2	\|a pubmed24n0682.xml
035			\|a (DE-627)NLM204636604
035			\|a (NLM)21188763
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	4	\|a The older Parkinson's disease drugs pergolide and cabergoline have been linked to heart problems. Are there any new Parkinson's drugs which are safer for patients with heart risks?
264		1	\|c 2009
336			\|a Text \|b txt \|2 rdacontent
337			\|a ohne Hilfsmittel zu benutzen \|b n \|2 rdamedia
338			\|a Band \|b nc \|2 rdacarrier
500			\|a Date Completed 05.01.2011
500			\|a Date Revised 01.12.2018
500			\|a published: Print
500			\|a Citation Status MEDLINE
650		4	\|a Journal Article
650		7	\|a Antiparkinson Agents \|2 NLM
650		7	\|a Dopamine Agonists \|2 NLM
650		7	\|a Ergolines \|2 NLM
650		7	\|a Pergolide \|2 NLM
650		7	\|a 24MJ822NZ9 \|2 NLM
650		7	\|a Cabergoline \|2 NLM
650		7	\|a LL60K9J05T \|2 NLM
773	0	8	\|i Enthalten in \|t Heart advisor \|d 1999 \|g 12(2009), 8 vom: 18. Aug., Seite 8 \|w (DE-627)NLM098274252 \|x 1523-9004 \|7 nnns
773	1	8	\|g volume:12 \|g year:2009 \|g number:8 \|g day:18 \|g month:08 \|g pages:8
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_NLM
912			\|a GBV_ILN_350
951			\|a AR
952			\|d 12 \|j 2009 \|e 8 \|b 18 \|c 08 \|h 8